Guidance document : special access program for drugs : guidance document for industry and practitioners. : H164-303/2020E-PDF
"Health Canada’s Special Access Program for drugs (SAP) enables drugs that are not marketed in Canada to be requested by practitioners for the treatment, diagnosis, or prevention of serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. Non-marketed drugs may be unauthorized if they have not been approved by Health Canada. This means they have not been assessed for safety, effectiveness and quality. It may also mean that the sale of the drug has not commenced in Canada, or the product has been discontinued or removed from the market due to regulatory actions under the Food and Drug Regulations (FDR)"--Introduction, page 6.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.893231&sl=1
| Ministère/Organisme |
|
|---|---|
| Titre | Guidance document : special access program for drugs : guidance document for industry and practitioners. |
| Variante du titre |
|
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Édition ultérieure | Guidance document : |
| Format | Texte numérique |
| Document électronique | |
| Note(s) |
|
| Information sur la publication |
|
| Description | 1 online resource (29 pages) |
| ISBN | 9780660365572 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 200275 |
| Descripteurs |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.Détails de la page
- Date de modification :